एट्राक्यूरियम के इंटरैक्शन

Avoid concomitant use with neuromuscular blocking agents. (क्विनीन लेबल, चेतावनियां और सावधानियां)

The possibility of the occurrence of neuromuscular blockage and respiratory paralysis should be considered if neomycin is administered, especially to patients receiving anesthetics, neuromuscular blocking agents such as tubocurarine, succinylcholine, decamethonium, or in patients receiving massive transfusions of citrate anticoagulated blood. (नियोमाइसिन लेबल, बॉक्स्ड चेतावनी)

During therapy with ZEMDRI, monitor for adverse reactions associated with neuromuscular blockade, particularly in high-risk patients, such as patients with underlying neuromuscular disorders (including myasthenia gravis) or in patients concomitantly receiving neuromuscular blocking agents [see Warning and Precautions (5.3) ] . (प्लाज़ोमाइसिन लेबल, बॉक्स्ड चेतावनी)

In the case of life-threatening muscle rigidity, a rapid onset neuromuscular blocker or naloxone may be administered. (रेमिफेंटानिल लेबल, चेतावनियां और सावधानियां)

Rocuronium Bromide Injection is contraindicated in patients known to have hypersensitivity (e.g., anaphylaxis) to rocuronium bromide or other neuromuscular blocking agents [see Warnings and Precautions ( 5.2 )] . (रोक्यूरोनियम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol. (एट्राक्यूरियम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Reversal of Neuromuscular Blocking Agents Other Than Rocuronium or Vecuronium Do not use BRIDION to reverse blockade induced by nonsteroidal neuromuscular blocking agents such as succinylcholine or benzylisoquinolinium compounds. (सुगैमाडेक्स लेबल, चेतावनियां और सावधानियां)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (एट्राक्यूरियम लेबल, चेतावनियां)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (एट्राक्यूरियम लेबल, चेतावनियां)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

• Neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. (क्लिंडामाइसिन लेबल, दवाओं के इंटरैक्शन)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Myopathy Patients receiving corticosteroids, including EMFLAZA, and concomitant therapy with neuromuscular blocking agents (e.g., pancuronium) or patients with disorders of neuromuscular transmission (e.g., myasthenia gravis) may be at increased risk of developing acute myopathy. (डेफ्लाज़ाकॉर्ट लेबल, चेतावनियां और सावधानियां)

Neuromuscular Blocking Agents Anesthetic concentrations of desflurane at equilibrium (administered for 15 or more minutes before testing) reduced the ED 95 of succinylcholine by approximately 30% and that of atracurium and pancuronium by approximately 50% compared to N 2 O/opioid anesthesia (see Table 4). (डेसफ्लुरेन लेबल, दवाओं के इंटरैक्शन)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Piperacillin and Tazobactam for Injection and Sodium Chloride Injection may prolong the neuromuscular blockade of vecuronium and other non-depolarizing neuromuscular blockers. (पाइपेरासिलिन और टैज़ोबैक्टम लेबल, दवाओं के इंटरैक्शन)

Depolarizing neuromuscular blocking agents: Increased effect. (पाइरिडोस्टिग्मिन लेबल, दवाओं के इंटरैक्शन)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

• Risks of Skeletal Muscle Rigidity and Skeletal Muscle Movement : Manage with neuromuscular blocking agent. (फेंटानिल लेबल, चेतावनियां और सावधानियां)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (एट्राक्यूरियम लेबल, चेतावनियां)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Drug Interactions Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; therefore, it should be used with caution in patients receiving such agents. (लिनकोमाइसिन लेबल, दवाओं के इंटरैक्शन)

Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (एट्राक्यूरियम लेबल, चेतावनियां)

Neuromuscular Blocking Agents Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing). (वेरापामिल लेबल, दवाओं के इंटरैक्शन)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (एट्राक्यूरियम लेबल, दवाओं के इंटरैक्शन)

Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (एट्राक्यूरियम लेबल, चेतावनियां)

When used to supplement alfentanil-N 2 O anesthesia, sevoflurane and isoflurane equally potentiate neuromuscular block induced with pancuronium, vecuronium or atracurium. (सेवोफ्लुरेन लेबल, दवाओं के इंटरैक्शन)

N e uromuscular Blocking Agents Resistance to the neuromuscular blocking action of the nondepolarizing neuromuscular blocking agents pancuronium, vecuronium, rocuronium and cisatracurium has occurred in patients chronically administered carbamazepine. (कार्बामाज़ेपिन लेबल, दवाओं के इंटरैक्शन)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (एट्राक्यूरियम लेबल, चेतावनियां)

Norepinephrine Dopamine Neuromuscular Blocking Agents Succinylcholine May cause sudden extrusion of potassium from muscle cells causing arrhythmias in patients taking digoxin. (डिगॉक्सिन लेबल, दवाओं के इंटरैक्शन)

In patients who have received neuromuscular blocking agents, doxapram may temporarily mask the residual effects of these drugs. (डॉक्साप्राम लेबल, दवाओं के इंटरैक्शन)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (एट्राक्यूरियम लेबल, चेतावनियां)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (एट्राक्यूरियम लेबल, चेतावनियां)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (एट्राक्यूरियम लेबल, चेतावनियां)

Common Neuromuscular Blocking Agents DIPRIVAN does not cause a clinically significant change in onset, intensity or duration of action of the commonly used neuromuscular blocking agents (e.g., succinylcholine and nondepolarizing muscle relaxants). (प्रोपोफोल लेबल, दवाओं के इंटरैक्शन)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (एट्राक्यूरियम लेबल, चेतावनियां)

Neuromuscular blocking agents Cisatracurium, pancuronium, rocuronium and vecuronium: resistance to the neuromuscular blocking action of the nondepolarizing neuromuscular blocking agents has occurred in patients chronically administered phenytoin. (फेनिटोइन लेबल, दवाओं के इंटरैक्शन)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (एट्राक्यूरियम लेबल, चेतावनियां)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (एट्राक्यूरियम लेबल, चेतावनियां)

Neuromuscular blocking agents Cisatracurium, pancuronium, rocuronium and vecuronium: resistance to the neuromuscular blocking action of the nondepolarizing neuromuscular blocking agents has occurred in patients chronically administered phenytoin. (फॉस्फेनिटोइन लेबल, दवाओं के इंटरैक्शन)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (एट्राक्यूरियम लेबल, चेतावनियां)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (एट्राक्यूरियम लेबल, चेतावनियां)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (एट्राक्यूरियम लेबल, चेतावनियां)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (एट्राक्यूरियम लेबल, चेतावनियां)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (एट्राक्यूरियम लेबल, चेतावनियां)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (एट्राक्यूरियम लेबल, चेतावनियां)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (एट्राक्यूरियम लेबल, चेतावनियां)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (एट्राक्यूरियम लेबल, चेतावनियां)

Alfentanil and Atracurium Ondansetron does not alter the respiratory depressant effects produced by alfentanil or the degree of neuromuscular blockade produced by atracurium. (ओन्डैनसेट्रॉन लेबल, दवाओं के इंटरैक्शन)

Neuromuscular Blockers In one study of 10 healthy adult volunteers, administration of PRECEDEX for 45 minutes at a plasma concentration of one ng/mL resulted in no clinically meaningful increases in the magnitude of neuromuscular blockade associated with rocuronium administration. (डेक्समेडेटोमिडिन लेबल, दवाओं के इंटरैक्शन)